Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

FARGO: A Randomised, Phase IIa, Multi-centre, Placebo-controlled Trial of FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis

NCT06286709 is registered in ClinicalTrials.gov with University of Birmingham as lead sponsor.

NCT NCT06286709
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06286709 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
FARGO: A Randomised, Phase IIa, Multi-centre, Placebo-controlled Trial of FAecal Microbiota Transplantation in primaRy sclerosinG chOlangitis
Lead sponsor
University of Birmingham
Phase
Phase 2
Overall status
Recruiting
Start date
March 27, 2024
Completion date
September 30, 2027
Enrollment
58 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

inflammatory bowel diseases, primary sclerosing cholangitis